Interlead electrical delays and scar tissue:response to cardiac resynchronization therapy in patients with ischemic cardiomyopathy by Tahri, Jasmine Borg et al.
 
  
 
Aalborg Universitet
Interlead electrical delays and scar tissue
response to cardiac resynchronization therapy in patients with ischemic cardiomyopathy
Tahri, Jasmine Borg; Hansen, Thomas Fritz; Storkås, Hanne Stavø; Lauridsen, Trine
Kiilerich; Olsen, Flemming Javier; Iversen, Allan; Lindhardt, Tommi Bo; Bruun, Niels Eske;
Søgaard, Peter; Risum, Niels
Published in:
PACE - Pacing and Clinical Electrophysiology
DOI (link to publication from Publisher):
10.1111/pace.13652
Publication date:
2019
Document Version
Accepted author manuscript, peer reviewed version
Link to publication from Aalborg University
Citation for published version (APA):
Tahri, J. B., Hansen, T. F., Storkås, H. S., Lauridsen, T. K., Olsen, F. J., Iversen, A., Lindhardt, T. B., Bruun, N.
E., Søgaard, P., & Risum, N. (2019). Interlead electrical delays and scar tissue: response to cardiac
resynchronization therapy in patients with ischemic cardiomyopathy. PACE - Pacing and Clinical
Electrophysiology, 42(5), 530–536. https://doi.org/10.1111/pace.13652
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.

 
 
 
This article has been accepted for publication and undergone full peer review but has not been 
through the copyediting, typesetting, pagination and proofreading process, which may lead to 
differences between this version and the Version of Record. Please cite this article as doi: 
10.1111/pace.13652. 
 
This article is protected by copyright. All rights reserved. 
 
Interlead electrical delays and scar tissue; response to cardiac resynchronization therapy in patients 
with ischemic cardiomyopathy 
 
Short title: Interlead electrical delays and CRT 
 
Jasmine Borg Tahri MD1, Thomas Fritz Hansen MD, PhD1, Hanne Stavø Storkås MD1, Trine 
Kiilerich Lauridsen MD, PhD1, Flemming Javier Olsen MD1, Allan Iversen MD, PhD1, Tommi 
Bo Lindhardt MD, Associate Professor 2, Niels Eske Bruun MD DMSc, Professor3, Peter 
Søgaard MD, DMSc, Associate Professor4, Niels Risum MD, PhD2 
 
1 Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark 
2 Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, 
Copenhagen, Denmark 
3 Department of Cardiology, Herlev and Gentofte Hospital, University of 
Copenhagen, Copenhagen, Denmark; Clinical Institute, Aalborg University, Aalborg, 
Denmark 
4 Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark 
 
 
This study was supported by the Independent Research Fund Denmark 
 
Corresponding author: 
1Jasmine Borg Tahri MD 
Department of Cardiology 
 
 
 
This article is protected by copyright. All rights reserved. 
 
2 
Gentofte University Hospital 
DK 2900 Hellerup 
Denmark 
Phone: + 47 41405153 
E-mail: jasminebt91@gmail.com 
Condensed abstract 
Interlead electrical delays (IEDs) and left ventricular scar tissue were measured in 68 
patients with ischemic cardiomyopathy and LBBB before CRT implantation. Patients with a 
long RV-LV-IED at implantation were most prone to respond to CRT independently of scar 
tissue and QRS duration. CRT did not change the duration of IEDs even among patients 
with LV remodeling.  
What’s new? 
 It has been questioned whether interlead electrical delays are useful markers of 
respond in the presence of scar tissue. In a cohort of ischemic CRT patients IEDs during 
implant and baseline scar tissue by MRI were measured.  
 
 RV-LV-IED was an independent marker of response in CRT patients with ischemic 
cardiomyopathy even in the presence of scar tissue.  
 
 RV-LV-IED may be particular useful in patients with QRS < 150 ms. 
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 CRT did not influence RV-LV-IED over time.  
Abstract 
Background:  
 The importance of interlead electrical delays (IEDs) in the presence of scar tissue for 
response to cardiac resynchronization therapy (CRT) in patients with ischemic 
cardiomyopathy is poorly described.  
 
Methods: 
Sixty-eight CRT patients with ischemic cardiomyopathy and left bundle branch block 
were included. IEDs, the time between sensing of native impulse at the RV-lead and LV-
lead, were measured at implantation and after eight months. MRI was used for assessment 
of scar tissue. Echocardiographic response was defined as  15% decrease in left 
ventricular end-systolic volume. NYHA class, Minnesota Living with Heart Failure 
Questionnaire and 6-minute walk-test were used to assess clinical response.  
 
Results 
A total of 44 patients (65 %) were responders to CRT. At implantation, IEDs were 
significantly longer among responders compared to non-responders (RV-LV-IED: 87 ms  33 
ms vs. 65 ms  47 ms, p < 0,05), most evident in patients with QRS < 150 ms. Responders 
had less myocardial scar tissue than non-responders (1  0,5 vs. 1,4  0,6, p = 0,01). 
However, in the multivariate model including QRS-duration and scar tissue, IEDs were 
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independently associated with LV remodeling after CRT: OR 3,99 [95% CI 1,02-15,7] (p = 
0,04). 
During the course of treatment, no changes were observed in IEDs among 
echocardiographic responders.  
 
Conclusion: 
RV-LV-IED was an independent marker of response in CRT patients with ischemic 
cardiomyopathy even in the presence of scar tissue and may be particular useful in patients 
with QRS < 150 ms. CRT did not influence this measurement over time.  
 
Keywords: Cardiac resynchronization therapy, heart failure, interlead electrical delay, 
ischemic cardiomyopathy.  
 
List of abbreviations: 
6MWT = 6-min walking test 
ACEI = angiotensin converting enzyme inhibitor 
ARB = angiotensin receptor blocker 
BB = beta blocker 
CABG = coronary artery bypass grafting  
CRT = cardiac resynchronization therapy  
DCM = non-ischemic dilated cardiomyopathy  
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ECG = electrocardiogram 
EGM = electrogram 
GFR = glomerular filtration rate 
HF = heart failure 
ICD = implantable cardioverter defibrillator  
IHD = ischemic heart disease  
IED = interlead electrical delay 
LBBB = left bundle branch block 
LV = left ventricle 
LVEF = left ventricular ejection fraction  
LVESV = left ventricular end-systolic volume 
MI = myocardial infarction 
MLHFQ =Minnesota living with heart failure questionnaire 
MRI = magnetic resonance imaging 
NYHA = New York Heart Association (functional classes of heart failure) 
pLV-sRV-IED = paced left ventricle to sensed right ventricle interlead electrical delay 
pRV-sLV-IED = paced right ventricle to sensed left ventricle interlead electrical delay 
RV-LV-IED = sensed right ventricle to left ventricle interlead electrical delay 
RV-LV-IED/QRS-d = RV-LV-IED divided by surface ECG QRS-duration  
STS = Scar tissue score 
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Introduction 
Selection of patients who will respond to cardiac resynchronization therapy (CRT) 
can be challenging. The primary target for CRT is an electrical substrate of significant left 
ventricle (LV) activation delay. Any method that reliably reflects such a delay may be useful 
in identifying CRT-responders. (1-3) Most patients with left bundle branch block (LBBB) have 
a significant LV activation delay presumably amenable to CRT. However, 
electrophysiological mapping studies indicate that around 1/3 of patients with LBBB defined 
by ECG do not have a significant LV activation delay. (4, 5) ECG-changes due to 
hypertrophy, LV-dilatation, isolated fascicular blocks or slowed intraventricular conduction 
may be misinterpreted as true LBBB. (6, 7) The electrical delays measured between the right 
ventricle (RV) and LV may serve as markers of favorable outcome to CRT. (6, 8-10) In 
contrast to more comprehensive approaches such as endocardial mapping, interlead 
electrical delays (IEDs) can easily be obtained during CRT implantation. The electrical time 
distance between native impulse sensing in the RV-lead and LV-lead (RV-LV-IED) may be 
considered as an indirect measurement of the activation delay in the LV. Thus, a relatively 
long RV-LV-IED suggests a beneficial response to CRT. (6, 8, 10, 11) One pitfall using IEDs 
is the presence of scar tissue in the LV which may cause prolonged activation times in the 
absence of a well-defined substrate for CRT. Accordingly, the value of IEDs in patients with 
ischemic cardiomyopathy in particular has been questioned. (6, 12, 13) 
The aim of this study was to investigate the prognostic utility of IEDs in CRT patients 
with ischemic cardiomyopathy including the importance of left ventricular scar tissue. 
Furthermore, we evaluated the relationship between changes in LV volumes and IEDs in the 
course of treatment.  
 
 
 
This article is protected by copyright. All rights reserved. 
 
7 
Methods 
Study population 
Between October 2009 and July 2012 seventy consecutive patients were 
prospectively enrolled in the study and underwent successful implantation of a biventricular 
pacemaker at Gentofte University Hospital in Denmark (65 patients) and Lund University 
Hospital in Sweden (5 patients). Patients fulfilled the following criteria at the time of 
implantation: left ventricular ejection fraction (LVEF)  35%, sinus rhythm, left bundle branch 
block (LBBB), QRS interval  120 ms, New York Heart Association (NYHA) functional class 
II or III and optimal pharmacologic treatment (maximally tolerated dosages of beta-blockers, 
ACE-inhibitors/angiotensin-II receptor blockers and spironolactone). All patients had 
ischemic heart disease defined as > 70% stenosis in one or more epicardial coronary artery 
diagnosed by coronary catheterization or prior myocardial infarction (MI) or coronary artery 
bypass graft surgery (CABG). Patients were excluded if they had significant primary valve 
disease, chronic atrial fibrillation, dementia or mental retardation, severe claustrophobia or 
metal implants contraindicative of magnetic resonance scan, acute coronary syndrome 
within 3 months, severe kidney insufficiency (GFR < 35 ml/min/1,73m2) and severe health 
condition threatening short-term survival.  
 
Device implantation and programming 
 All patients were implanted with a CRT-device with defibrillator capacity (CRT-
D) from St. Jude Medical (St. Paul, MN). One lead was implanted in the right atrium, a right 
ventricular lead was placed on the septum and the left ventricular lead was placed preferably 
in a lateral position. Only patients with > 92 % biventricular pacing was included. 
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Echocardiography 
A full standard echocardiography was performed at baseline (the time for CRT-
implantation) and after 8 months. All echocardiographic studies were performed on Vivid 9 
ultrasound machines (GE Healthcare, Horten, Norway). All analyses were performed off-line 
blinded to outcome using EchoPac PC (version BT11 GE Vingmed Ultrasound).  imp on   
method of discs as an average of three measurements was used to measure left ventricular 
end systolic volumes (LVESV) and left ventricular ejection fraction (LVEF).  
 
Interlead electrical delays (IEDs) 
IEDs were measured at CRT implantation and after 8 months with CRT, using an 
automated function in the St-Jude device. Three different IEDs were measured; RV-LV-IED, 
pRV-sLV-IED and pLV-sRV-IED. RV-LV-IED was defined as the time interval in milliseconds 
between sensing of the native impulse at the RV-lead and LV-lead. pRV-sLV-IED was 
defined as the time interval between pacing at the RV-lead and sensing at the LV-lead, and 
pLV-sRV-IED was defined as the delay between pacing at the LV-lead and sensing at the 
RV-lead. To account for beat-to-beat variations all intervals were averaged over eight 
consecutive beats. RV-LV-IEDs were also adjusted to surface ECG QRS-duration to account 
for individual differences in myocardial size. The RV-LV-IED was divided by the QRS-
duration at baseline and given as a proportion of the QRS-duration (RV-LV-IED/QRS-d).  
 
Cardiac Magnetic Resonance Imaging scan analysis 
A General Electric 1.5 Tesla CV scanner was used with 8-channel cardiac coil. For 
late gadolinium enhancement imaging, 0.1 mmol/kg of gadolinium was injected and imaging 
started after 10 minutes delay in short axis and multiple long axis views. Cardiac gated 
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segmented inversion-recovery prepared gradient echo pulse sequence was used with field 
of view 38-42 cm, matrix of 256 x 192-256, slice thickness of 7-8 mm, interslice gap of 2-3 
mm, inversion time of 175-300 ms, adjusted to null normal myocardial signal. The optimal 
inversion time that nulls normal myocardium was determined by acquiring multiple images of 
the same midventricular view using different inversion times. ReportCard software (General 
Electric, Waukesha WI 4.2) was used to quantify scar tissue by manual tracing. The left 
ventricle was divided into sixteen regions. Percent scar tissue in the regions of interest 
(%ROI) was scored from zero to four; 0 (%ROI 0-1), 1 ( 1-24), 2 ( 15-49), 3 ( 50-74), 4 ( 
75-100). Scar tissue score was defined as the mean of scar tissue scores in all 16 regions.  
 
Clinical outcome and definition of responders 
The primary outcome variable was left ventricle reverse remodeling, measured with 
echocardiography at baseline and after 8 months. A significant left ventricle reverse 
remodeling and response to CRT was defined as patients with a decrease in left ventricular 
end-systolic volume (LVESV)  15% after eight months. Volumes were analyzed as absolute 
values. Clinical response was defined as an improvement in NYHA functional class by one 
or more,  10 % reduction in score on the MLHFQ, or  10 % improvement in the 6MWT at 
eight months follow-up. 
 
Statistical Analysis 
Statistical analysis was performed using SPSS 24 for Mac. Descriptive statistics were 
reported as mean  standard deviation for normally distributed continuous variables and 
reported as proportions for categorical variables. Normality was tested by Shapiro-Wilk test, 
box-plot wa  created to check for outlier  and Levene’  te t wa  a  e  ed to check for 
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homogeneity of variances. Differences between mean data were compared with 
independent-samples t-test and differences in proportions were compared by applying chi-
square-te t or Fi her’  exact te t. A p-value < 0,05 was considered significant for all tests. 
The  pearman’  rank-order correlation was run to measure whether there was an 
association between the percentages of electrical (RV-LV-IED) and anatomical (LVESV) 
reverse remodeling. To determine whether there was a monotonic relationship between the 
variables a visual inspection of a scatterplot of the two variables was performed. Receiving 
operating characteristic curve analysis was used to identify the optimal cut-off value for RV-
LV-IED and for RV-LV-IED/QRS-duration that could best discriminate between responders 
and non-responders. The value that maximized the area under the ROC curve (AUC) was 
used as the optimal cut-point. Candidate variables with p -values < 0,1 in univariate analysis 
were included in the multivariable regression model using backward selection to test the 
independent association with outcome. 
This study complies with the Declaration of Helsinki. The research protocol was 
approved by the locally appointed ethics committee, and informed consent of the subjects 
has been obtained. 
 
Results 
Out of 70 patients, one patient was excluded due to early LV lead displacement and 
one patient died before CRT implantation. The study population included 19 % women and 
had a mean age of 69  8 years. All the patients had LBBB and ischemic cardiomyopathy. 
The patients were mostly in NYHA functional class III (79 %), with a wide QRS-complex (160 
 20 ms), increased LVESV (146  62 ml) and impaired LVEF (27  7 %). In general, the 
patients were medically optimized.  
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Response to CRT 
 
Echocardiographic response 
After eight months follow-up 44 out of 68 (65 %) patients showed significant LV 
reverse remodeling (LVESV from 152  29 ml to 104  55 ml, p < 0,001), non-responders; 
(LVESV from 134  44 ml to 138  43 ml, p = 0,296). 
 
Clinical response 
Sixty out of sixty-eight patients (88 %) had clinical effect with improvement in either 
NYHA functional class, MLHFQ or 6MWT distance. Improvement in NYHA functional class 
was seen in 38/68 patients (56 %), 46/65 (71 %) showed significant improvement on MLHFQ 
and 32/59 (54 %) improved significantly in 6-minute walking test distance.  
 
Response in relation to IEDs 
Baseline characteristics according to echocardiographic response are presented in 
Table 1. RV-LV-IED was significantly longer among responders compared to non-
responders (87  33 vs. 65  47 ms, p = 0,047). Responders to CRT also had a significantly 
longer RV-LV-IED adjusted to surface ECG QRS-duration (RV-LV-IED/QRS-d) compared to 
non-responders (p = 0,026). The response rates for each quartile of RV-LV-IED/QRS-d are 
demonstrated in Figure A demonstrating the importance of a certain degree of activation 
delay for CRT response. With regards to the other IEDs there were no significant differences 
between responders and non-responders at baseline.  
For patients with QRS-durations of 120-149 ms RV-LV-IED was significantly longer 
among responders compared to non-responders (75  19 vs. 48  32 ms, p = 0,035). For 
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patients with QRS-durations of 150 ms or more there was no significant difference in the RV-
LV-IED between responders and non-responders (90  36 vs. 79  54 ms, p = 0,498). Using 
the median for RV-LV-IED, in a model with QRS-duration, IED was still independently 
associated with LV remodeling after CRT: OR 3,99 [95% CI 1,02-15,7] (p = 0,04). 
 
Clinical response 
 Responders, assessed with improvement in 6 minutes walking distance, had a 
significantly longer RV-LV-IED/QRS-d compared to non-responders (p = 0,049). RV-LV-IED 
 50 % of the surface ECG QRS-duration showed a tendency of association to response in 
NYHA functional class (p = 0,064). Otherwise, no significant association between IEDs and 
clinical parameters were present.  
 
Cut-off values for IEDs 
The cut-off value for RV-LV-IED that best predicted LV reverse remodeling after CRT 
was 46 ms (sensitivity 87 %, specificity 62 %) and for RV-LV-IED/QRS-d the optimal cut-off 
value was 0,33 (area under the curve 0,70, 95 % CI 0,58 – 0,80; p = 0,007; sensitivity 87 %, 
specificity 54 %). Among patients with RV-LV-IED/QRS-d < 0,33 only 23 % were 
echocardiographic responders (p = 0,001).  
In multivariate analysis including sex, age and scarburden an IED/QRS > 0,33 was 
highly associated with significant LV reverse remodeling: HR 7,3 [95% CI 2,04-26,10] (p= 
0,002). IED as a continuous variable was found to be borderline significant in the multivariate 
model: OR 1,02 [95% CI 0,99-1,033] (p= 0,06). 
However, the cut-off value was not useful for identification of clinical responders with 
regards to improvement in NYHA functional class, MLHFQ or 6MWT distance, see Figure B.  
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Electrical remodeling 
IEDs do not change over time and are independent of LV volume changes. After 
eight months of CRT no significant changes in RV-LV-IED/QRS-d were observed among 
echocardiographic responders (from 0,54  0,20 to 0,57  0,22, p = 0,205) or non-
responders (from 0,37  0,21 to 0,39  0,26, p = 0,556). The same applied for the other 
IEDs. Overall there was no difference in changes of the IEDs (RV-LV-IED/QRS-d) over 
time between responders and non-responders (p = 0,386).  
Accordingly, no correlation was demonstrated between changes in LVESV and RV-
LV-IED/QRS-d,  pearman’  rho wa  0,109 and the correlation coefficient wa  not statistically 
significant (p = 0,384). The same applied when continuous variables where used, 
spearman’  rho wa  0,2 and the correlation coefficient wa  not statistically significant (p = 
0,194). Similarly, no correlation was found between decrease in LVESV and the other IEDs. 
The linear regression model comparing the percent change in LVESV and RV-LV-IED 
showed that a 10 ms increase in baseline RV-LV-IED was associated with a 1,4 % decrease 
in LVESV.  [95% CI -0.0026-0.00056], (p= 0,04). 
However, a significant decrease in the QRS-duration was observed after CRT among 
echocardiographic responders (from 162  20 ms to 136  22 ms, p < 0,001). 
 
IEDs and scar tissue 
Patients with a long RV-LV-IED/QRS-d ( 0,33) had more myocardial scar tissue 
than patients with a short RV-LV-IED/QRS-d (< 0,33) (1,0  0,5 vs. 1,4  0,5, p = 0,040). 
There were more responders among patients with long RV-LV-IED/QRS-d and a low scar 
tissue burden (below 1,19) than in the other patient groups, but the difference was not 
statistically significant (p = 0,065), see Figure C.  
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 Even among patients with echocardiographic response and a low scar tissue 
burden no changes were observed in IEDs over time (RV-LV-IED/QRS-d: from 0,53  0,2 
to 0,56  0,04, p = 0,378). 
 
Discussion 
The importance of IEDs for response to CRT patients with ischemic cardiomyopathy 
is poorly described. In the present study the role for scar tissue and IEDs were investigated 
in a cohort of ischemic CRT patients. 
The study demonstrated that 
1) The IEDs (RV-LV-IED) are useful markers of response in CRT-patients with 
ischemic cardiomyopathy independent of scar tissue.  
2) IEDs may be particularly useful among patients with QRS less than 150 ms. 
3) After LV reverse remodeling no changes in IEDs can be demonstrated, and 
changes in IEDs and LV-volumes are not correlated.  
 
The use of the RV-LV-IED to evaluate the LV activation delay and the association 
with CRT response has been investigated throughout recent years. Gold et al (14) used QLV 
(the time interval from the onset of QRS at surface ECG to the first peak by the LV lead at 
the sensed electrogram) and reported that patients with IEDs in the highest quartile had a 
significantly better chance of reverse remodeling response and improvement in quality of life 
after CRT. Later, the same group showed that long IEDs (this time measured as RV-LV 
duration) were also associated with improved outcome based on a composite end point of 
HF hospitalization or death. (15) Similarly, smaller studies have suggested that RV-LV-IED, 
 
 
 
This article is protected by copyright. All rights reserved. 
 
15 
as used in the present study, can be related to echocardiographic response as well as 
symptomatic benefits. (6, 8, 10, 12, 15-18) 
It has been questioned whether prolonged IEDs are useful as markers of response in 
the presence of scar tissue. (4, 6) Scar tissue may cause prolonged IEDs without the 
presence of an electrical substrate well-suited for CRT. The current study confirms the 
importance of IEDs for response to CRT specifically in patients with ischemic 
cardiomyopathy. Thus, prolonged IEDs were associated with a favorable CRT-response 
independent of scar tissue. Interestingly, our data further suggest that IEDs may be 
particularly useful in patients with QRS between 120-149 ms. Responders and non-
responders in this group separated quite clearly numerically in IED values. The data 
suggests that some patients with QRS 120-149 ms do not have a significant activation delay 
in the LV despite LBBB by ECG. Short IEDs (presuming anatomical separation) support 
such cases.  
It is well-known that patients with ischemic heart disease (IHD) benefit less from CRT 
than other HF patients. (19-21) Emerek et al. (6) reported that patients with IHD had 
significantly shorter and more heterogeneous RV-LV-IEDs likely to result in less LV reverse 
remodeling after CRT compared to patients with non-ischemic dilated cardiomyopathy 
(DCM). Our results support that a large variety in IEDs exists among CRT-patients with IHD. 
Patients with long IEDs were found to have slightly more scar tissue but seemingly without 
compromising the predictive value.  
The importance of interlead electrical delays fits well with the concept of the working 
mechanism behind CRT. A significant activation delay of the LV must be present for CRT to 
have an optimal effect, and the importance of a long IED may not be surprising. The clinical 
implications on the other hand is still not clear. A role for IEDs may suggest a strategy of 
evaluating interventricular electrical delay at the time of LV lead implantation with the goal of 
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achieving as long an IED as possible. This may include repositioning of the LV lead or 
changing the pacing site in case of a quadripolar LV-lead. (15) 
A national multicenter CRT study regarding IED-guided CRT (Danish-CRT) has now 
been initiated to elucidate questions like this.  
 
Only few studies have looked at the impact of other IEDs on CRT response, such as the 
paced IEDs between the RV and LV-leads. (6, 9, 22) Emerek et al. (6) found no relation to 
CRT-outcome for pRV-sLV-IED or pLV-sRV-IED. In agreement, the current study did not 
show any association between pRV-sLV-IED or pLV-sRV-IED and CRT-outcome. RV-LV-
IED depicts the actual conduction disease better than the other IEDs and therefore is 
superior to pRV-sLV-IED and pLV-sRV-IED in identifying significant LV activation delay such 
as in the presence of a true LBBB activation. The value of RV-LV-IED and RV-LV-IED/QRS-
d corresponding with the highest accuracy in predicting CRT response was 46 ms and 0,33 
respectively, for the current study.  
 
The relationship between electrical and anatomical reverse remodeling was recently 
inve tigated by D’Onofrio et al. (23) in a sub-analysis of CRT-MORE. They demonstrated 
that LV reverse remodeling yields some decrease in RV-LV-IED after 6 months, but the 
variable  where not found  ignificantly correlated to each other. D’Onofrio et al proposed a 
different time course of the electrical and anatomical reverse remodeling as one explanation 
of the lack of association. The present study had an observation time of 8 months and 
confirmed their results. Our findings did not support the hypothesis that a reduction in LV-
volume correlate to a reduction in IEDs. Although patients with a long RV-LV-IED/QRS-d 
showed a great potential of LV reverse remodeling, they underwent minimal electrical 
changes (assessed by IEDs) and this was independent of the LV scar burden. It appears 
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that CRT correct conduction delays, but does not improve the electrical substrate and thus 
IEDs will remain unchanged even in the presence of LV volume changes.  
It has been proposed that the QRS-duration should be corrected by the heart size 
when selecting patients for CRT. Based on the present study it is not likely that the QRS-
duration should be dependent on changes of heart size.  
 
Limitations 
Patients with IHD show dispersion in their electrical activation pattern, the optimal 
anatomical position may not correspond to the optimal electrical position and the LV-lead 
may not be positioned at the latest activated site in every patient. The vast majority of LV-
leads were placed in a postero-lateral branch of the sinus coronaries thought to be the latest 
activated site in case of LBBB. Placement of the LV lead in other areas may cause 
misinterpretation regarding LV activation time.  
The findings in this article are based on an automated feature from St. Jude to 
measure IEDs. This feature uses manual measurements from the intracardiac EGM. It is 
comparable to Q-LV measurements although individual differences are observed. 
Consequently, cutoff-values are not interchangeable between studies using different 
methods.  
IEDs may be partly dependent on both RV and LV lead location. As mentioned in the 
method section the RV-leads were typically placed in the mid-distal septum. The LV-lead 
preferentially in a (postero)-lateral branch of the coronary sinus. The values for IEDs may not 
be comparable to other implanting centers where the RV-lead is preferably placed in the 
apex. 
This study was performed in patients with LBBB and sinus rhythm. The results do not 
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necessarily apply to other CRT-patients.  
In total 11 patients did not have MRI with scar assessment. This was due to poor 
image quality (3), claustrophobia (3), other reasons (5).  
 
Conclusion 
RV-LV-IED was an independent marker of response in CRT patients with ischemic 
cardiomyopathy even in the presence of scar tissue and may be particular useful in patients 
with QRS < 150 ms. CRT did not influence IEDs over time.  
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Table 1 
Clinical characteristics of studied patients by responders and non-responders 
 Responders (n = 
44) 
Non-responders (n = 
24) 
p -value 
Characteristics 
Age (years) 69  7 69  9 0,947 
Male, n (%) 33 (75) 22 (92) 0,117 
Prior CABG, n (%) 19 (43) 13 (57) 0,318 
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21 
Prior MI, n (%) 23 (52) 6 (25) 0,041* 
Diabetes, n (%) 13 (30) 4 (19) 0,386 
HT, n (%) 26 (59) 14 (58) 1 
HC, n (%) 37 (84) 16 (67) 0,129 
Creatinin (mmol/L) 102  30 102  39 0,992 
BMI (kg/m2) 26  4 27  4 0,298 
NYHA III, n (%) 35 (80) 19 (80) 1 
MLHFQ 42  22 36  16 0,233 
6MWT (meters) 384  109 366  85 0,432 
QRS-d (msec) 162  20 156  19 0,175 
QRS-d  150, n (%) 32 (73) 11 (46) 0,037* 
Scar-tissue score 1,0  0,5 1,4  0,6 0,006* 
LVEF (%) 27  8 28  7 0,451 
LVESV (ml) 152  69 135  44 0,208 
RV-LV-IED (msec) 87  33 65  47 0,047* 
RV-LV-IED/QRS-d 0,5  0,2 0,4  0,3 0,026* 
RV-LV-IED  50% of 
QRS-d 
24 (55) 7 (29) 0,074 
pRV-sLV-IED 162  22 162  30 0,91 
pRV-sLV-IED/QRS-d 1  0,2 1  0,2 0,479 
pLV-sRV-IED (msec) 142  32 146  34 0,665 
pLV-sRV-IED/QRS-d 0,9  0,2 1  0,2 0,217 
Medications 
ACEI/ARB, n (%) 43 (98) 23 (96) 1 
BB, n (%) 40 (91) 23 (96) 0,649 
Diuretic, n (%) 35 (80) 19 (79) 1 
Spiron, n (%) 30 (68) 15 (63) 0,789 
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Statin, n (%) 41 (93) 21 (88) 0,658 
CABG = coronary artery bypass surgery; MI = myocardial infarction; HT = hypertension; HC 
= hypercholesterolemia; BMI = body mass index; NYHA = New York Heart Association 
function classification; MLHFQ = Minnesota living with heart failure questionnaire; 6MWT = 6 
minutes walking test; QRS-d = QRS-duration; LVEF = left ventricular ejection fraction; 
LVESV = left ventricular end-systolic volume; RV-LV-IED = sensed right ventricle to left 
ventricle interlead electrical delay; pRV-sLV-IED = paced right ventricle to sensed left 
ventricle interlead electrical delay; pLV-sRV-IED = paced left ventricle to sensed right 
ventricle interlead electrical delay; ACEI/ARB = angiotensin-converting enzyme inhibitorer / 
angiontensin receptor blocker; BB = beta-blocker; spiron = spironolacton 
 
Figure legends 
 
 
 
Figure A: Echocardiographic response in relation to RV-LV-IED/QRS-d quartiles.  
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Figure B: The percentage of echocardiographic and clinical responders and non-
responders in patients based on a cut-off for RV-LV-IED/QRS-d at 0,33. 
 
 
Figure C: The percentage of echocardiographic responders and non-responders 
divided by high or low IED (defined as RV-LV-IED/QRS-d above or below the cut-off 
value at 0,33) and high or low scar (defined as a scar tissue score above or below 
1,19). 
 
